News
Health-care companies rose as some beaten-down stocks recouped some of their losses. UnitedHealth Group rose by more than 7%, but remain more than one-third lower for the year to date. Similarly, ...
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.
The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax's COVID-19 vaccine, but only for certain ...
Members of the World Health Organization voted emphatically in favour of a potentially groundbreaking global treaty on ...
The FDA has approved Novavax’s COVID-19 vaccine, Nuvavoxid, for use in adults 65 and older and in individuals ages 12-64 who have at least one underlying health condition. The approval is based on ...
RFK Jr. pledged not to upend US vaccine system, but big changes are underway. It's unclear which shots will be available.
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results